Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
NanoString Technologies, Inc. develops innovative molecular profiling tools for the life sciences and diagnostics markets, particularly focused on spatial biology and genomic analysis. Its flagship product, the GeoMx Digital Spatial Profiler, allows researchers to analyze tissue samples with high precision, setting it apart in the competitive landscape of medical instruments.
NanoString generates revenue primarily through the sale of its advanced genomic analysis instruments and consumables, which are priced at a premium due to their unique capabilities. The company also benefits from recurring revenue through service contracts and consumable sales, providing a stable cash flow stream.
Adoption rates of GeoMx Digital Spatial Profiler in research institutions
Partnerships with pharmaceutical companies for drug development
Regulatory approvals for new diagnostic applications
Overall funding levels in life sciences research
Technological disruption from emerging genomic technologies
Regulatory changes affecting diagnostic product approvals
Intense competition from established players like Illumina and Thermo Fisher
Potential for new entrants with disruptive technologies
High debt-to-equity ratio (5.47) raises concerns about financial stability
Negative operating cash flow indicates liquidity challenges
moderate - As a supplier to research institutions and pharmaceutical companies, NanoString's performance is somewhat linked to overall healthcare spending and R&D budgets, which can be sensitive to economic cycles.
Higher interest rates may increase financing costs for the company, impacting its ability to invest in growth initiatives. Additionally, higher rates could dampen overall healthcare spending.
minimal - The company is not heavily reliant on credit markets for operations, although high debt levels could pose risks if financing conditions tighten.
growth - Investors looking for high-growth opportunities in the biotech sector may find NanoString appealing due to its innovative products.
high - The stock has experienced significant volatility due to its financial struggles and market conditions.